Spear Holdings RSC Ltd Buys Shares of 200,942 UnitedHealth Group Incorporated $UNH

Spear Holdings RSC Ltd purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 200,942 shares of the healthcare conglomerate’s stock, valued at approximately $62,688,000. UnitedHealth Group comprises about 4.6% of Spear Holdings RSC Ltd’s portfolio, making the stock its 9th largest position.

Several other institutional investors have also recently made changes to their positions in the business. Country Club Bank boosted its holdings in UnitedHealth Group by 120.6% during the second quarter. Country Club Bank now owns 18,567 shares of the healthcare conglomerate’s stock worth $5,739,000 after buying an additional 10,151 shares in the last quarter. Seamount Financial Group Inc. lifted its position in UnitedHealth Group by 4.7% during the second quarter. Seamount Financial Group Inc. now owns 818 shares of the healthcare conglomerate’s stock worth $255,000 after buying an additional 37 shares in the last quarter. SteelPeak Wealth LLC raised its position in UnitedHealth Group by 68.7% in the second quarter. SteelPeak Wealth LLC now owns 10,070 shares of the healthcare conglomerate’s stock valued at $3,141,000 after purchasing an additional 4,101 shares during the period. Drake & Associates LLC grew its stake in shares of UnitedHealth Group by 27.9% in the second quarter. Drake & Associates LLC now owns 1,420 shares of the healthcare conglomerate’s stock valued at $443,000 after buying an additional 310 shares in the last quarter. Finally, Heck Capital Advisors LLC grew its stake in shares of UnitedHealth Group by 27.1% in the second quarter. Heck Capital Advisors LLC now owns 1,859 shares of the healthcare conglomerate’s stock valued at $580,000 after buying an additional 396 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH opened at $358.95 on Tuesday. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The company has a market cap of $325.09 billion, a P/E ratio of 15.55, a PEG ratio of 2.34 and a beta of 0.47. The stock has a fifty day moving average price of $309.38 and a 200 day moving average price of $352.34.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the prior year, the business earned $6.80 earnings per share. The firm’s revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on UNH shares. UBS Group restated a “buy” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Piper Sandler reduced their price objective on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a report on Wednesday, July 30th. KeyCorp reduced their price objective on UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating for the company in a report on Wednesday, July 30th. Oppenheimer reduced their price objective on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Finally, Bank of America boosted their price target on UnitedHealth Group from $290.00 to $325.00 and gave the stock a “neutral” rating in a report on Monday, August 18th. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and four have issued a Sell rating to the stock. According to MarketBeat, UnitedHealth Group currently has an average rating of “Hold” and an average price target of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.